Treatments for Alcohol Dependence: Rethinking the Role of Comorbidity and Clinical Subtypes

Dr. Patkar has received research/grant support from Abbott; Forest Pharmaceuticals, which markets acamprosate; Lundbeck; Merck; Ortho-McNeil Pharmaceuticals, manufacturer of topiramate; Pfizer, manufacturer of sertraline; Titan Pharmaceuticals; and Shire. Dr. Patkar also has received consultant honoraria from Bristol-Myers Squibb and Reckitt Benckiser; serves on the speaker's bureaus for Alkermes, which manufactures injectable naltrexone, and Pfizer; and has received advisory board fees or CME honoraria from Bristol-Myers Squibb, Merck, and Reckitt Benckiser. Dr Li reports no financial relationships with commercial interests. Dr. Freedman has reviewed this editorial and found no evidence of influence from these relationships.